French drug delivery specialist MedinCell is teaming up with Novartis' generic division Sandoz to develop controlled-release drugs with a focus on cancer.
POPULAR COMMENT THREADS
Struggling injection device specialist Unilife said in an SEC filing that it needs an additional week to negotiate a deal with potential savior Amgen, which would involve the big biotech purchasing up to 19.9% of the company's stock in return for a much-needed cash infusion. If the grand alliance pans out, Amgen would also gain the preferred right of access to new drug delivery platforms and enter into a manufacturing arrangement with Unilife.
Researchers at Philadelphia's Drexel University have developed a microscopic "crystal ball" that could someday be used for drug delivery.
Malvern, PA's Scilex Pharmaceuticals is seeking to deploy its transdermal drug delivering patch to break into the post-herpetic neuralgia market, which is led by an Endo drug that had peak sales of $1.4 billion.
Spero Therapeutics raises $30M to support its drug delivery platform targeting Gram-negative bacteria
Cambridge, MA's Spero Therapeutics has raised $30 million in Series B financing to develop its so-called Potentiator Platform to improve existing antibiotics by enabling them to pass through the cell membrane of Gram-negative bacteria.
Flamel Technologies officials sold the $20.25 million takeover of Charlotte, NC's FSC Pediatrics as part of the company's "journey from a pure drug delivery company to a diversified specialty pharma company," but then went on to describe how each of the new products in its portfolio counts drug delivery as one of its key differentiators. Whether done purposefully or not, it just goes to show the importance of drug delivery, even to those who strive to be diversified players.
Several drug delivery devices are on a draft list of med tech that will be subject to a final guidance calling for the application of human factors and usability engineering to medical devices.
From Our Sister Sites
Mumbai-based Sun Pharmaceutical Industries wants the U.S. FDA to re-inspect its troubled Halol plant between April and June after efforts at answering complaints from a leaky ceiling that were first noted in September 2014 and some of which were highlighted in a December 2015 warning letter as still pending.
Pfizer Consumer Healthcare announced the launch of joint health and wellness innovation program that will enable 10 med tech startups to utilize the San Francisco office of tech industry incubator Galvanize.